In conclusion, our preliminary findings suggest that six FDG PET texture features may serve as potential non-invasive biomarkers for predicting PD-L1 expression in patients newly diagnosed with NSCLC when tissue samples are not available. This evidence concerns the gene CD274 and non-small cell lung carcinoma.